Related Experiment Video
Updated: Nov 17, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Cardiac Fibroblasts Play Pathogenic Roles in Idiopathic Restrictive Cardiomyopathy
Hirofumi Tsuru1, Hidekazu Ishida1, Jun Narita1
1Department of Pediatrics, Osaka University Graduate School of Medicine.
Insights
Restrictive cardiomyopathy (RCM) involves impaired heart muscle relaxation. This study found that cardiac fibroblasts (CFs) from RCM patients worsen cardiomyocyte relaxation, suggesting CFs play a key role in RCM pathology.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Biology
Background:
- Restrictive cardiomyopathy (RCM) is defined by impaired ventricular relaxation.
- Genetic mutations don't fully explain RCM, suggesting other cellular mechanisms are involved.
- The role of cardiac fibroblasts (CFs) in RCM pathogenesis is not well understood.
Purpose of the Study:
- To investigate the pathological role of cardiac fibroblasts (CFs) in restrictive cardiomyopathy (RCM).
- To analyze the cellular physiology and gene expression of CFs from RCM patients.
- To assess the impact of RCM-derived CFs on cardiomyocyte function.
Main Methods:
- Established primary cell cultures of CFs from four RCM patients.
- Co-cultured RCM-derived CFs with healthy cardiomyocytes (direct and indirect).
- Performed RNA sequencing on RCM-derived CFs and analyzed gene expression profiles.
Main Results:
- RCM-derived CFs significantly impaired cardiomyocyte relaxation velocity.
- No significant changes were observed in CF proliferation, apoptosis, migration, activation, or attachment.
- RNA sequencing revealed distinct gene expression profiles in RCM-derived CFs, with dysregulated extracellular matrix and cytokine expression.
Conclusions:
- Altered gene expression in RCM-derived CFs negatively impacts cardiomyocyte relaxation.
- Changes in extracellular matrix composition and cytokine secretion by CFs may contribute to RCM pathology.
- Cardiac fibroblasts are implicated as a significant factor in the development of restrictive cardiomyopathy.
Background:
Restrictive cardiomyopathy (RCM) is characterized by impaired ventricular relaxation. Although several mutations were reported in some patients, no mutations were identified in cardiomyocyte expressing genes of other patients, indicating that pathological mechanisms underlying RCM could not be determined by cardiomyocytes only. Cardiac fibroblasts (CFs) are a major cell population in the heart; however, the pathological roles of CFs in cardiomyopathy are not fully understood.
Methods And Results:
This study established 4 primary culture lines of CFs from RCM patients and analyzed their cellular physiology, the effects on the contraction and relaxation ability of healthy cardiomyocytes under co-culture with CFs, and RNA sequencing. Three of four patients hadTNNI3mutations. There were no significant alterations in cell proliferation, apoptosis, migration, activation, and attachment. However, when CFs from RCM patients were co-cultured with healthy cardiomyocytes, the relaxation velocity of cardiomyocytes was significantly impaired both under direct and indirect co-culture conditions. RNA sequencing revealed that gene expression profiles of CFs in RCM were clearly distinct from healthy CFs. The differential expression gene analysis identified that several extracellular matrix components and cytokine expressions were dysregulated in CFs from RCM patients.
Conclusions:
The comprehensive gene expression patterns were altered in RCM-derived CFs, which deteriorated the relaxation ability of cardiomyocytes. The specific changes in extracellular matrix composition and cytokine secretion from CFs might affect pathological behavior of cardiomyocytes in RCM.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Introduction to Fibroblasts

